Paul Blanchfield
President chez LANTHEUS HOLDINGS, INC.
Fortune : 6 M $ au 31/03/2024
Postes actifs de Paul Blanchfield
Sociétés | Poste | Début | Fin |
---|---|---|---|
LANTHEUS HOLDINGS, INC. | President | 20/03/2023 | - |
Chief Operating Officer | 15/06/2022 | 20/03/2023 | |
Corporate Officer/Principal | 27/01/2020 | 15/06/2022 |
Historique de carrière de Paul Blanchfield
Anciens postes connus de Paul Blanchfield
Sociétés | Poste | Début | Fin |
---|---|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | - | - |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Formation de Paul Blanchfield
Duke University | Undergraduate Degree |
Stanford University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Royaume-Uni | 2 |
Japon | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
LANTHEUS HOLDINGS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Bourse
- Insiders
- Paul Blanchfield
- Expérience